NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine

Fishbein, T.; Novitskiy, G.; Mishra, L.; Matsumoto, C.; Kaufman, S.; Goyal, S.; Shetty, K.; Johnson, L.; Lu, A.; Wang, A.; Hu, F.; Kallakury, B.; Lough, D.; Zasloff, M.
March 2008
Gut;Mar2008, Vol. 57 Issue 3, p323
Academic Journal
Background: Intestinal allograft rejection resembles Crohn's disease clinically and pathologically. An understanding of its mechanism could impact this life-saving procedure, as well as provide insight into the pathophysiology of inflammatory bowel disease. The NOD2 protein has been implicated as a key player in intestinal immune health, as a consequence of the discovery of three polymorphisms linked with Crohn's disease. An investigation was carried out to determine whether epithelial immune function and graft survival were influenced by NOD2 mutations in an intestinal transplant population. Methods: The NOD2 genotypes of 34 transplants performed consecutively over the past 3 years were determined. The NOD2 genotypes were related to clinical outcomes and the expression of certain intestinal antimicrobial peptides (AMPs) believed to protect the epithelium. Results: An unexpectedly high percentage of recipients, 35%, possessed NOD2 polymorphisms, while 8.6% of donors had comparable mutations. The likelihood of allograft failure was about 100-fold higher in recipients with mutant NOD2 alleles compared with recipients with wild-type NOD2 loci. Rejection in NOD2 mutant recipients was characterised by decreased expression of certain Paneth cell and enterocyte AMPs, prior to the onset of epithelial injury and inflammation. Conclusions: Crohn's disease-associated polymorphisms in the NOD2 gene in the recipient represent a critical immunological risk factor for intestinal allograft rejection. Compromised epithelial defences precede visible epithelial injury and inflammatory infiltration. The association of impaired epithelial immunity with the recipient's genotype suggests that certain NOD2-expressing cells of haematopoietic origin play a role in the process, perhaps by regulating expression of certain epithelial AMPs within the allograft.


Related Articles

  • Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin’s lymphoma. Lan-Ping Diao; Xiao-Ming Yu; Yu-Huan Gao; Yan Li; Hai-Sheng Liu; Li-Hong Liu; Rong-Miao Zhou; Na Wang; Li-Li Wu; Shi-Jie Wang // Journal of Cancer Research & Clinical Oncology;Nov2009, Vol. 135 Issue 11, p1473 

    Vascular endothelial growth factor (VEGF) plays an important role in tumor angiogenesis and cancer progression. The VEGF genetic polymorphisms were shown to be independently associated with an adverse outcome in various malignancies. We investigated the possible associations of two polymorphisms...

  • The new genetics of bone marrow transplantation. Allen, R D // Genes & Immunity;Jun2000, Vol. 1 Issue 5, p316 

    There is now little doubt that functional immune polymorphism exists and can exert a significant effect on the severity of immunologic disease. Studies in this area are driven by the belief that an understanding of the influence of immune polymorphism on immunologic disease will improve our...

  • Umbilical Cord Blood Offers Another Option for Leukemia Patients. Christensen, Damaris // JNCI: Journal of the National Cancer Institute;2/16/2005, Vol. 97 Issue 4, p253 

    Reports on the transplants that use bone marrow grafts that are mismatched for one antigen or that use stem cell-rich blood taken from umbilical cords soon after birth. Advantages offered by cord blood over bone marrow; Studies that indicate cord blood recipients tended to be younger and sicker...

  • HDAC Inhibition and Graft Versus Host Disease. Sung Choi; Reddy, Pavan // Molecular Medicine;May/Jun2011, Vol. 17 Issue 5/6, p404 

    Histone deacetylase (HDAC) inhibitors are currently used clinically as anticancer drugs. Recent data have demonstrated that some of these drugs have potent antiinflammatory or immunomodulatory effects at noncytotoxic doses. The immunomodulatory effects have shown potential for therapeutic...

  • Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients. Terakura, S; Murata, M; Nishida, T; Emi, N; Akatsuka, Y; Morishima, Y; Kodera, Y; Naoe, T // Bone Marrow Transplantation;Feb2006, Vol. 37 Issue 4, p381 

    Treatment-related mortality (TRM) is a major obstacle to successful allogeneic hematopoietic stem cell transplantation (HSCT). A variety of drugs are used in allogeneic HSCT, and a genetic polymorphism in metabolic enzymes could affect the metabolism of drugs and potentially influence TRM. Here,...

  • Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Lawler, M.; Locasciulli, A.; Longoni, D.; Schiro, R.; McCann, S. R. // Bone Marrow Transplantation;3/1/2002, Vol. 29 Issue 5, p453 

    Presents a case report on the treatment of leukemia and severe aplastic anemia through allogeneic blood or bone marrow transplantation (BMT). Description of the patient; Molecular studies; Significance of DNA polymorphisms in the assessment of hemapoietic chimaerism following allogeneic BMT.

  • Polymorphisms in the coding region of mtDNA and effects on clinical outcome of unrelated bone marrow transplantation. Ishikawa, Y; Kashiwase, K; Okai, M; Ogawa, A; Akaza, T; Morishima, Y; Inoko, H; Sasazuki, T; Kodera, Y; Juji, T // Bone Marrow Transplantation;9/15/2001, Vol. 28 Issue 6, p603 

    The entire protein-coding region was divided into 45 fragments, separately amplified and analyzed for polymorphism by the PCR-SSCP (single-strand conformation polymorphism) method. The effect of polymorphism mismatching on the clinical outcome of unrelated bone marrow transplantation was studied...

  • Cutaneous T-Cell Lymphoma Lesional Epidermal Cells Activate Autologous CD4+ T Lymphocytes: Involvement of Both CD1+OKM5+ and CD1+OKM5+ Antigen-Presenting Cells. Hansen, Erik R.; Baadsgaard, Ole; Lisby, Steen; Cooper, Kevin D.; Thomsen, Kristian; Vejlsgaard, Gunhild L. // Journal of Investigative Dermatology;Apr90, Vol. 94 Issue 4, p485 

    Cutaneous T-cell lymphoma is characterized by infiltration of the skin by activated CD4+ T lymphocytes. The mechanism by which these T lymphocytes achieve and maintain their activated state is unknown. Antigen-specific activation of T lymphocytes is dependent upon antigen-presenting cells which...

  • Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection. Kazutomo Suzue; Seiki Kobayashi; Tsutomu Takeuchi; Mamoru Suzuki; Shigeo Koyasu // International Immunology;Mar2008, Vol. 20 Issue 3, p337 

    The onset of Th1 immunity is in part regulated by genetic background. To elucidate the cell type carrying critical factors determining the Th1 response, we employed Rag-2−/− mice on Leishmania major-susceptible BALB/c and -resistant B10.D2 backgrounds. By using bone marrow (BM)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics